BRONCHOSCOPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Global Bronchoscopy Market Size and Forecast – 2026 to 2033

The global bronchoscopy market is estimated to be valued at USD 3,745.5 Mn in 2026 and is expected to reach USD 5,500.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033. This growth is driven by the increasing prevalence of respiratory diseases, technological advancements in bronchoscopy procedures, and rising adoption of minimally invasive diagnostic and therapeutic interventions worldwide.

Key Takeaways of the Global Bronchoscopy Market

• Product segment is expected to lead the global bronchoscopy market, capturing 72.0% share in 2026.
• Diagnosis segment is estimated to represent 68.57% of the global bronchoscopy market share in 2026.
• Disposable segment is projected to dominate with 63.6% of the global bronchoscopy market share in 2026.
• North America is expected to lead the market, holding a share of 41.2% in 2026. Europe is anticipated to be the fastest-growing region, with 23.1% share in 2026.

Market Overview

• The global bronchoscopy market is expanding as lung cancer remains a major global burden and health systems push earlier diagnosis through bronchoscopy-based biopsy and staging pathways.
• Rising use of low dose Computed Tomography (CT) screening is increasing the detection of small and peripheral lung nodules, which is directly supporting demand for advanced bronchoscopy procedures.
• Technology is the biggest growth engine, with robotic bronchoscopy, EBUS, navigation platforms, and AI-enabled workflow upgrades improving access to hard-to-reach lesions.
• Single use bronchoscopy is gaining ground because hospitals want faster turnaround, lower reprocessing burden, and stronger infection control, with recent regulatory expansion into pediatric use adding momentum.

Currents Events and their Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Why Does the Product Segment Dominate the Global Bronchoscopy Market in 2026?

The product segment is expected to hold the largest market share of 72.0% in 2026, due to the continuous innovations and expanding clinical applications of these devices. Diagnostics and minimally invasive treatment are dominated by flexible bronchoscopes and their maneuverability as well as access to the more inaccessible areas of the respiratory tract. The flexibility increases the comfort of the patients and increases the range of the pulmonary assessment, hence compelled demands. On the same note, rigid bronchoscopes have not been forgotten as certain therapeutic procedures like the removal of tumors or foreign bodies will require the use of rigid bronchoscopes due to their strength and enhanced control during invasive surgery.

Tools, including forceps, brushes, and suction devices are also part of the accessories segment and they contribute significantly to the growth of the product category as they allow more specific diagnostic biopsy and treatment. The ongoing product development has resulted in miniaturization, high-quality imaging, and an added feature of integrating the advanced visualization techniques such as high-definition cameras and autofluorescence imaging. This development has seen bronchoscopy procedures become more effective, less invasive and have become more widely adopted in hospitals and other specialized pulmonary care centers.

For instance, in May 2024, Olympus launched two new bronchoscopes under its EVIS X1 Endoscopy System. The company said the diagnostic and therapeutic bronchoscopes offer a slimmer outer diameter, larger working channels, improved suction, and enhanced imaging, strengthening the bronchoscopes segment in routine diagnostic and therapeutic bronchoscopy.

(Source - Olympus)

Why Does the Diagnosis Segment Dominate the Global Bronchoscopy Market in 2026?

The diagnosis segment is expected to hold 68.57% of the market share in 2026, driven by the rising prevalence of respiratory disorders and the critical need for early detection. Bronchoscopy plays an indispensable role in diagnosing diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), bronchitis, and other airway-related pathologies including asthma. Among these, lung cancer diagnosis remains a primary driver due to the critical importance of early-stage detection in improving patient survival rates.

The bronchoscopy procedure allows physicians to visualize the airways directly, perform biopsies, and collect samples for histopathological analysis, which is central to accurate diagnosis. With respiratory diseases continuing to pose a significant global health burden, early and accurate diagnosis through bronchoscopy techniques is being prioritized. This prioritization is supported by enhanced imaging modalities embedded in bronchoscopes, including high-resolution and fluorescence imaging, which improve lesion detection and differentiation between benign and malignant tissues.

For instance, on January 9, 2026, FUJIFILM announced its new EB-710US flexible ultrasound bronchoscope for lung cancer detection and staging. The device was developed to support EBUS procedures with clearer ultrasound imaging, improved image depth, and a balloonless structure, strengthening the diagnostic bronchoscopy segment.

(Source - FUJIFILM)

The Disposable Segment Dominates the Global Bronchoscopy Market

The disposable segment is expected to hold the largest market share of 63.6% in 2026, propelled by growing concerns around infection control and operational efficiency in healthcare environments. Disposable bronchoscopes have gained widespread acceptance as they eliminate risks associated with cross-contamination between patients, a critical factor in clinical practice, especially in intensive care units and settings with immunocompromised individuals.

Infection control guidelines from global health authorities encourage the use of single-use medical devices to prevent hospital-acquired infections, which has accelerated the shift towards disposable bronchoscopes. These devices require no complex reprocessing or sterilization, reducing the burden on clinical staff and minimizing procedure turnaround time. This ease of use translates to improved patient safety and enhanced operational workflows.

The Rising Role of Bronchoscopy in Early Lung Cancer Diagnosis

• The global bronchoscopy market has a strong momentum whereby healthcare systems are emphasizing more on the early detection of lung cancer. Increased application of low-dose CT screening is causing increased identification of small and peripheral nodules in the lungs and this is directly driving up the demand for bronchoscopy that can confirm the diagnosis by the use of minimally invasive biopsy. This is rendering bronchoscopy a more central component in the lung cancer care pathway particularly in hospitals that are interested in minimizing diagnostic delays and enhancing better treatment planning.
• Concurrently, the market is enjoying the advantages of technological advancements like EBUS, navigation bronchoscopy and robotic-assisted bronchoscopy that have made doctors access hard-to-reach parts of lung lesions more accurately. The improvements are enhancing diagnostic capabilities and decreasing the reliance on increasingly invasive diagnostic modalities, a fact that is fueling adoption in advanced pulmonary care facilities. With the increase in the world to consider early detection a greater clinical issue, bronchoscopy has ceased to be a general diagnostic instrument and is becoming a tactical technology in the diagnosis and staging of cancers.

Regional Insights

To learn more about this report, Download Free Sample

North America Bronchoscopy Market Analysis and Trends

The North America region is projected to lead the market with a 41.2% share in 2026, driven by a well-established healthcare infrastructure, high adoption of advanced medical technologies, and strong presence of key industry players. The region enjoys huge government investments in healthcare research and effective regulation systems that ease the approval and adoption of new bronchoscopy devices and procedures. Also, the high rates of prevalence of respiratory diseases and widespread awareness of respiratory diseases lead to the demand of bronchoscopy procedures. Major manufacturers of medical devices like Medtronic, Boston scientific, and Olympus Corporation are enjoying extensive operations in the area and are continually deploying innovative bronchoscopes and other related technologies. The characteristic of North America market to have a highly developed ecosystem in the form of leading hospitals, specialist clinics and research institutes contributes to its continuous product innovation and clinical trials, which contribute to its leadership role.

For instance, in May 2025, CentraState Medical Center in the U.S. announced the launch of Ion robotic bronchoscopy to improve lung cancer diagnostic capabilities, especially for reaching small and hard to access lung nodules for biopsy. This is a strong diagnosis segment example because it directly supports earlier and more precise lung lesion detection in North America.

(Source - CentraState Medical Center)

Europe Bronchoscopy Market Analysis and Trends

The Europe region is expected to exhibit the fastest growth in the bronchoscopy market contributing 23.1% share in 2026, owing to increased emphasis on early diagnosis of lung cancer. The broader use of EBUS-based staging, and the increased use of the advanced bronchoscopy platform to diagnose peripheral lung lesions are driving the Europe bronchoscopy market. There are also increased technological improvements in the region, including Olympus launching the BF-UCP190F EBUS bronchoscope in EMEA in September 2025, and the heavy burden of lung cancer in Europe has contributed to the need to have more specific and less invasive pulmonary procedures. Simultaneously, the market is also conditioned by the pressure of the hospital budget and the necessity of trained operators, thus, the growth is most effective in the specialized centers that can afford to invest in advanced bronchoscopy because of the higher volumes of diagnoses and the improvement of clinical outcomes.

For instance, on March 2, 2026, Intuitive completed the acquisition of the da Vinci and Ion distribution business operated by ab medica, Abex, Excelencia Robótica, and affiliates in Southern Europe. This matters for the bronchoscope segment because it expands Intuitive’s direct commercial control over the Ion endoluminal robotic bronchoscopy system, strengthening product penetration in Europe.

(Source - Intuitive)

Global Bronchoscopy Market Outlook for Key Countries

How is the U.S. Helping in the Growth of the Bronchoscopy Market?

The U.S. bronchoscopy market is the rapid development of technology and the high level of integration of minimally invasive procedures into clinical practice. Large companies such as Medtronic and Boston Scientific keep on developing bronchoscopy systems that have better imaging and navigation features. Leading health providers and research centers allow clinical research to be common and the adoption of innovative devices to be made promptly. In addition, government initiatives to operate programs to manage respiratory diseases as well as reimbursement policies are in favor of the developing clinical uses of bronchoscopy in the diagnosis of lung cancer and chronic pulmonary diseases.

How is Germany Helping in the Growth of the Bronchoscopy Market?

Germany's mature healthcare system and high healthcare expenditure underpin the country’s stable market for bronchoscopy devices. The country is home to significant industry players such as Drägerwerk and KARL STORZ that have a rich legacy in endoscopic equipment manufacturing. Supportive regulatory policies and strong collaborations between medical device companies and research hospitals accelerate technological innovations and product approvals. The German market is noted for high adoption rates of rigid and flexible bronchoscopes in specialized pulmonary and thoracic surgery centers.

Key Drivers for the Growth of the China Bronchoscopy Market

The fast-growing healthcare infrastructure and growing concern in early diagnosis of lung diseases, including lung cancer, also makes China remain ahead of bronchoscopy market in Asia Pacific with its rapidly growing healthcare infrastructure. There are reforms and projects in government healthcare such as Healthy China 2030 that promote the use of advanced diagnostic technologies. Pentax Medical and FujiFilm are some of the examples of companies that have formed localized production and R&D facilities to meet the domestic demand. Having strategic partnering with Chinese hospitals will allow it to develop devices more specifically and implement training programs to have them more readily accepted and used.

India Bronchoscopy Market Trends

The market for bronchoscopy in India is changing rapidly owing to the growing urbanization trends, awareness on respiratory health and the advancement of healthcare service delivery mechanisms. Rural healthcare strengthening programs on enhancing healthcare services have augmented the supply of bronchoscopy services outside the metropolitan areas. In addition, introduction of international players like Olympus Corporation and Stryker and increasing domestic producers have increased the variety of products and made them affordable. New business models such as equipment leasing and pay-per-use have served to enter price sensitive segments in the country.

Pricing Pressure and Capital Budget Constraints in the Global Bronchoscopy Market

• Continued price pressure and capital budget pressure is a significant threat to the international bronchoscopy market. The advanced bronchoscopy systems, particularly robotic platforms, EBUS systems and imaging-integrated systems demand high initial investment to buy, and thus purchasing decisions are slow to reach by hospitals and diagnostic centers. Numerous healthcare providers, especially in cost-sensitive markets are still not upgrading or not adopting due to capital budgets being redirected to wider critical care and high-volume departments.
• This pressure is also compelling buyers to put the performance of the product aside and emphasize more on the overall cost of ownership, service support, efficiency of the procedure, and the payback period. This has made manufacturers experience tougher pricing negotiations and increasing requests on more adaptable business models, such as bundling, disposables-based methods, and value-based positioning. Within this climate, firms able to demonstrate clinical advantage as well as economic worth are better placed to gain market shares.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In September 2025, Olympus Corporation launched the BF-UCP190F EBUS bronchoscope in EMEA and APAC. The device was designed for real-time ultrasound-guided biopsy, with a slim outer diameter, shorter distal end, and stronger maneuverability to improve access to deeper lung regions and support more accurate lung cancer diagnosis and staging.
• In May 2025, Johnson & Johnson MedTech announced new clinical data for its MONARCH Platform for robotically assisted bronchoscopy from the TARGET study, published in CHEST Journal. The study covered 679 patients across 21 sites in the U.S., Canada, and Hong Kong, and the company said physicians reached small and peripheral lung nodules in over 98% of cases, supporting broader adoption of robotic bronchoscopy for lung biopsy procedures.
• In July 2024, Mary Washington Hospital announced the acquisition and deployment of Intuitive Surgical’s Ion robotic bronchoscopy system to enhance early lung cancer detection. The hospital stated that the system enables physicians to accurately reach and biopsy hard-to-access peripheral lung nodules using a thin, shape-sensing robotic scope. It highlighted that the technology improves diagnostic precision, reduces the need for repeat procedures, and supports earlier-stage detection, ultimately improving patient outcomes and reducing time to treatment.

Top Strategies Followed by Global Bronchoscopy Market Players

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Report Scope

Bronchoscopy Market Report Coverage

Global Bronchoscopy Market Dynamics

To learn more about this report, Download Free Sample

Global Bronchoscopy Market Driver - Rising Lung Cancer Burden

The growing number of cases of lung cancer cases in the world is a major contributor to the need of bronchoscopy procedure which is an important instrument in the diagnosis and treatment of this cancer. Since lung cancer is still among the major causes of cancer-related deaths in the world, early diagnosis and proper staging is now urgent in order to enhance patient survival. Its least invasive procedure allows doctors to see the airways, tissue biopsy, and evaluate the progression of cancer in a better way than the traditional ones do. Increased understanding of the significance of early and accurate diagnosis by healthcare providers, coupled with the development of the latest technologies in bronchoscopy has further promoted its usage in clinical practice.

For instance, in October 2025, Intuitive announced expanded AI and advanced imaging integration for its Ion robotic bronchoscopy platform, with a broader U.S. launch planned for 2026. The company said the upgrade was developed to support more efficient and accurate lung biopsy procedures, reinforcing the role of advanced bronchoscopy in responding to the rising burden of lung cancer and the growing need for earlier diagnosis of suspicious lung nodules.

(Source - Intuitive)

Global Bronchoscopy Market Opportunity - Growth in Robotic Bronchoscopy

The rise of robotic bronchoscopy systems gives the company a big growth prospect in the bronchoscopy market. Robotic bronchoscopy is more precise, and better navigating and can access peripheral lung lesions that are hard to reach using the traditional methods of bronchoscopy. This technology is especially essential in the circumstances of the increased number of cases of lung diseases, such as cancer, that require the proper diagnosis and treatment. Clinical applications of bronchoscopy are further boosting with the introduction of robotics and other advanced imaging modalities including electromagnetic navigation and real time 3D visualization. The systems allow to conduct minimally invasive biopsies, enhance the results of the procedure, and decrease the number of complications in patients, which is why they are appealing to healthcare professionals who need to make the quality of the provided care better.

Further, an increase in research and development by medical device manufacturers to develop next-generation robotic platforms is also hastening the introduction of new products into the market globally.

For instance, in March 2025, Johnson & Johnson MedTech announced the U.S. FDA clearance of MONARCH QUEST, an enhancement for the MONARCH Platform for robotically assisted bronchoscopy. The update added AI enhanced navigation and an open interface with GE HealthCare’s OEC 3D imaging system to improve access to hard-to-reach lung nodules, making it a strong product launch instance for growth in robotic bronchoscopy driving market expansion.

(Source - Johnson & Johnson MedTech)

Analyst Opinion (Expert Opinion)

• The global bronchoscopy market is expanding due to the rising cases of early lung cancer detection, increased robotized bronchoscopy and EBUS systems, and navigation systems, and single use bronchoscopes. The largest opportunity is the enhancement of access to small and peripheral lung lesions, yet, the high cost of the system and the constrained hospital budget are still significant obstacles, particularly in the case of more advanced robotic and imaging combined systems.
• As well, the market is being influenced by high-quality clinical engagement via conferences like the AACIP, ERS Congress, and World Congress for Bronchology and Interventional Pulmonology, which are contributing to increased training, sharing of knowledge and adoption of various technologies. Meanwhile, the innovation, broadening signals and real-life usage have been reinforcing the market prognosis by the recent launches and clearances of companies like Johnson & Johnson MedTech and Olympus.

Market Segmentation

• Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Product
    • Flexible Bronchoscopes
    • Rigid Bronchoscopes
  • Accessories
• Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Diagnosis
    • Lung Cancer Diagnosis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Bronchitis
    • Others (Asthma and Others)
  • Therapeutic
    • Tumor Resection
    • Foreign Body Removal
    • Stent Placement
    • Others (Airway Dilation and Others)
• Usability Insights (Revenue, USD Mn, 2021 - 2033)
  • Disposable
  • Reusable
• Patient Age Insights (Revenue, USD Mn, 2021 - 2033)
  • Adult
  • Pediatric
• End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Others (Research Centers and Others)
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Olympus Corporation
  • FUJIFILM Holdings Corporation
  • HOYA Corporation PENTAX Medical
  • Ambu A/S
  • Karl Storz SE & Co KG
  • Richard Wolf GmbH
  • Boston Scientific Corporation
  • Medtronic plc
  • Johnson & Johnson MedTech
  • Intuitive Surgical Inc
  • Noah Medical
  • Broncus Medical Inc
  • Micro-Tech Endoscopy
  • Hunan Vathin Medical Instrument Co Ltd
  • SCHÖLLY Fiberoptic GmbH

Sources

Primary Research Interviews

Industry Stakeholders list

• Interventional Pulmonologists
• Thoracic Surgeons
• Respiratory Physicians
• Bronchoscopy Suite Directors
• Hospital Procurement Managers
• Clinical Application Specialists

End Users list

• Tertiary Care Hospitals
• Pulmonary and Respiratory Care Centers
• Cancer Centers
• Ambulatory Surgical Centers
• Intensive Care Units
• Academic Medical Centers

Government and International Databases

• World Health Organization
• International Agency for Research on Cancer Global Cancer Observatory
• Centers for Disease Control and Prevention
• National Institutes of Health
• ClinicalTrials.gov
• OECD Health Statistics

Trade Publications

• MassDevice
• MedTech Dive
• Fierce Biotech MedTech
• Medscape Pulmonary Medicine
• Pulmonology Advisor
• Medical Device Network

Academic Journals

• Journal of Bronchology and Interventional Pulmonology
• Annals of the American Thoracic Society
• European Respiratory Journal
• European Respiratory Review
• Respiratory Research
• Clinics in Chest Medicine

Reputable Newspapers

• Financial Times
• The Wall Street Journal
• The New York Times
• The Guardian
• The Washington Post

Industry Associations

• American Thoracic Society
• European Respiratory Society
• American Association for Bronchology and Interventional Pulmonology
• American College of Chest Physicians
• International Association for the Study of Lung Cancer
• Society of Thoracic Surgeons

Public Domain Resources

• NCBI Bookshelf
• American Lung Association
• ATS Clinical Practice Guidelines
• ERS Publications

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years